focus -WSS

focus

author：hotspot 2025-09-03 03:31:18 - browse：8555

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： STAT Readout: Friday, Oct. 20 biotech updates

explore

WSS

Bacterial infection may be ‘key event’ in endometriosis, study says

STAT Summit: Ending the crisis of Black deaths in the U.S.

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

CZI to create biohub to build anti

STAT Summit: Ending the crisis of Black deaths in the U.S.

Why is France rioting? What to know about the fatal police shooting of Nahel M

entertainment

focus

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Medical leaders decry Supreme Court decision on affirmative action

Bacterial infection may be ‘key event’ in endometriosis, study says

The cancer drug shortage isn’t new — and neither are the solutions

FDA clears Verve to begin U.S. study of gene

Trump demands the U.S. pay no more for drugs than other countries … again

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Cancer drug shortages should be causing more outrage

Cassava Sciences’ Alzheimer’s clinical trials should be halted

leisure time

Cassava Sciences’ Alzheimer’s clinical trials should be halted

STAT Readout Newsletter: Biotech news today

Listen: PBM conflicts, RSV vaccines, & the future of flu season

When is a doctor not a doctor? Try when patients address women doctors

The problems with dementia villages

Doctor appointment wait times are getting worse

explore

entertainment

leisure time

knowledge